Tag Archives: Pfizer Inc.

Trump win sends pharma stocks up, while hospitals plunge; fate of Obamacare far from clear

Pharmaceutical stocks and bonds were among the day’s biggest winners Wednesday (November 9, 2016) as the sweeping Republican victory in US elections eased concern that price controls might be imposed… Read more »

Pfizer misses 3Q views but gets nod for Prevnar from China; Mao would scowl, but not Xi

More than a year after pulling its vaccines out of one of the world’s most challenging but lucrative drug markets, Pfizer has moved back into China with a thumbs up for top-selling… Read more »

Johnson & Johnson Tumbles as Pfizer Set to Launch Remicade Biosimilar; Solid 3rd Quarter Doesn’t Quell Market’s Overreaction

Thriving pharmaceutical sales drove stellar quarterly results for Johnson & Johnson (New Brunswick NJ), but the company’s shares fell 3% so far this week on worries that its smash hit,… Read more »

Bristol Myers Clobbered as Cancer Drug Disappoints; Rival Merck Unanimous Winner at Medical Conference

New data are likely to prompt doctors to abandon Bristol-Myers Squibb Co.’s (New York City) immunotherapy Opdivo in favor of Merck & Co.’s (Kenilworth NJ) rival Keytruda in a large… Read more »

Glaxo Settles Bribery Charges with SEC for $20 Million; Cozy Relation of Pharma with Docs a Thing of the Past?

GlaxoSmithKline PLC (London) will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses,… Read more »

Tenet to Pay $553 Million to Settle Kickback Allegations; Culture of Corruption Dates Back Decades

Tenet Healthcare Corp. (Dallas TX) and two of its Atlanta subsidiaries have agreed to pay more than $513 million to resolve criminal and civil claims accusing the chain of paying… Read more »

Pfizer Wins Bidding War for Medivation; But Why Bother?

Pharmaceutical giant Pfizer Inc. (New York City) is paying $14 billion to buy Medivation Inc. (San Francisco), a biotech company that sells a high-priced prostate cancer medication discovered by UCLA, according to the… Read more »

U.S. Doctors, Hospitals Receive Billions from Drug, Device Makers; Report

Drug and device makers sustained their payments to doctors and teaching hospitals at nearly $6.5 billion last year, according to the figures released Thursday from a federal database. And physicians… Read more »

New Type of Non-Opioid Pain Drug Seeks FDA Approval

ELI LILLY & CO. (Indianapolis IN) said it and partner Pfizer Inc. (New York City) aim to seek approval by 2018 for a new type of pain drug that could… Read more »

Pfizer Acquires Anacor Pharma for $5.2 Billion

Pfizer Inc. (New York City) is buying Anacor Pharmaceuticals Inc. (Palo Alto CA) in a $5.2 billion deal to add an eczema gel to its portfolio, just a month after… Read more »